Learning Objectives

  1. Explain pharmacogenomics and identify opportunities for impact within oncology
  2. Discuss progression of guidance for 5FU / DPYD
  3. Evaluate results from PGx implementations within oncology
  4. Recognize future opportunities and evaluate barriers to utilization of PGx
Session date: 
05/14/2026 - 8:00am to 9:00am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dyson Wake, PharmD